Prognostic Model for De Novo and Recurrent Metastatic Breast Cancer

PURPOSE: Metastatic breast cancer (MBC) has a heterogeneous clinical course. We sought to develop a prognostic model for overall survival (OS) that incorporated contemporary tumor and clinical factors for estimating individual prognosis. METHODS: We identified patients with MBC from our institution...

Descripción completa

Detalles Bibliográficos
Autores principales: Barcenas, Carlos H., Song, Juhee, Murthy, Rashmi K., Raghavendra, Akshara S., Li, Yisheng, Hsu, Limin, Carlson, Robert W., Tripathy, Debu, Hortobagyi, Gabriel N.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2021
Materias:
ORIGINAL REPORTS
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807018/
https://www.ncbi.nlm.nih.gov/pubmed/34351787
http://dx.doi.org/10.1200/CCI.21.00020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8807018/
https://www.ncbi.nlm.nih.gov/pubmed/34351787
http://dx.doi.org/10.1200/CCI.21.00020

Ejemplares similares